Makers Laboratories Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and approve Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Makers Laboratories Ltd has informed BSE that its Board of Directors will meet on Friday, 7th November 2025, to consider and approve the Standalone and Consolidated Unaudited Financial Results for the second quarter and half year ended 30th September 2025. The notice is filed under SEBI Listing Regulations (Regulation 29 read with 47). The company's insider trading window remains closed from 1st October 2025 until 9th November 2025, covering the period up to 48 hours after the results are declared. No financial figures or performance details have been disclosed in this filing, which is purely a pre-results procedural intimation.
This is a routine regulatory intimation with no direct impact on the stock. Investors should watch for the actual Q2/H1 FY26 results on or after 7th November 2025 to assess the company's earnings performance and any forward-looking commentary.